8-K: Nexalin Technology Reduces At-the-Market Offering to $3.1 Million

Nexalin Technology amended its equity distribution agreement to reduce the maximum offering price of its common stock through an at-the-market program to $3.1 million.

Summary

• Nexalin Technology, Inc. has amended its equity distribution agreement with Maxim Group LLC.
• The amendment reduces the maximum amount of shares that can be sold through the at-the-market (ATM) offering from $9,777,825 to $3,100,000.
• As of May 5, 2025, approximately $3.1 million in shares remain available for sale under the ATM Program.
• The shares will be issued pursuant to an effective shelf registration statement on Form S-3.
• This Form 8-K does not constitute an offer to sell or a solicitation of an offer to buy any securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company is reducing the size of its ATM offering, it still has access to capital. The reduction could be due to various factors, not necessarily negative.

Positives

• The company retains the flexibility to raise capital through the ATM program, albeit at a reduced amount.
• The amendment provides clarity on the amount of shares available for sale under the ATM program.

Negatives

• The reduction in the offering size may indicate a change in the company's capital needs or market conditions.
• The company is limiting its potential access to capital.

Risks

• The company may not be able to raise the full $3.1 million if market conditions are unfavorable.
• The sale of shares through the ATM program could dilute existing shareholders.
• Failure to raise sufficient capital could impact the company's ability to execute its business plan.

Future Outlook

The company may sell shares of its common stock from time to time through Maxim Group LLC, as exclusive sales agent, up to an aggregate offering price of $3,100,000.

Industry Context

ATM offerings are a common method for companies to raise capital, particularly for smaller companies or those with volatile stock prices. Reducing the size of an ATM offering could reflect a change in the company's capital needs or a response to market conditions.

Comparison to Industry Standards

• ATM offerings are frequently used by companies in the biotech and technology sectors to raise capital incrementally.
• The size of the offering is relatively small compared to ATM programs of larger, more established companies.
• Comparable companies might include other small-cap technology firms utilizing ATM offerings to fund operations or research and development.

Stakeholder Impact

• Shareholders may experience dilution if the company sells shares through the ATM program.
• The company's ability to fund its operations and growth may be affected by the reduced offering size.

Next Steps

• The company may sell shares of its common stock through the ATM program as market conditions allow.
• The company will continue to file prospectus supplements related to the offering of the shares.

Key Dates

Keywords

at-the-market offering, equity distribution agreement, common stock, Nexalin Technology, Maxim Group LLC, ATM Program, capital raise